BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35145687)

  • 1. First reported case of delayed-type hypersensitivity reaction to non-hyaluronic acid Polycaprolactone dermal filler following COVID-19 vaccination: A case report and a review of the literature.
    Kalantari Y; Sadeghzadeh-Bazargan A; Aryanian Z; Hatami P; Goodarzi A
    Clin Case Rep; 2022 Feb; 10(2):e05343. PubMed ID: 35145687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid soft tissue filler delayed inflammatory reaction following COVID-19 vaccination - A case report.
    Michon A
    J Cosmet Dermatol; 2021 Sep; 20(9):2684-2690. PubMed ID: 34174156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review on COVID-19 vaccination and cosmetic filler reactions: A focus on case studies and original articles.
    Kalantari Y; Aryanian Z; Mirahmadi SM; Alilou S; Hatami P; Goodarzi A
    J Cosmet Dermatol; 2022 Jul; 21(7):. PubMed ID: 35534886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2.
    Savva D; Battineni G; Amenta F; Nittari G
    Int J Infect Dis; 2021 Dec; 113():233-235. PubMed ID: 34597761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reaction to Hyaluronic Acid Dermal filler following novel Coronavirus infection - a case report.
    Rowland-Warmann MJ
    J Cosmet Dermatol; 2021 May; 20(5):1557-1562. PubMed ID: 33735503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed inflammatory reaction to hyaluronic acid lip filler after the Pfizer-BioNTech COVID-19 vaccine: A case report.
    Neamatallah T
    Heliyon; 2023 Jul; 9(7):e18274. PubMed ID: 37539264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity reaction to hyaluronic acid dermal filler after COVID-19 vaccination: A series of cases in São Paulo, Brazil.
    Ortigosa LCM; Lenzoni FC; Suárez MV; Duarte AA; Prestes-Carneiro LE
    Int J Infect Dis; 2022 Mar; 116():268-270. PubMed ID: 35063676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed hypersensitivity reaction to cosmetic filler following two COVID-19 vaccinations and infection.
    Azzouz S; Lanoue D; Champagne K; Genest G
    Allergy Asthma Clin Immunol; 2023 Apr; 19(1):31. PubMed ID: 37076880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late onset hypersensitivity reaction to hyaluronic acid dermal fillers manifesting as cutaneous and visceral angioedema.
    Alawami AZ; Tannous Z
    J Cosmet Dermatol; 2021 May; 20(5):1483-1485. PubMed ID: 33342068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid delayed inflammatory reaction after third dose of SARS-CoV-2 vaccine.
    Calvisi L
    J Cosmet Dermatol; 2022 Jun; 21(6):2315-2317. PubMed ID: 35384252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between BNT162b2 vaccination and the development of delayed inflammatory reactions to hyaluronic acid-based dermal fillers-A nationwide survey.
    Safir A; Samuelov L; Sprecher E; Daniely D; Artzi O
    J Cosmet Dermatol; 2022 Oct; 21(10):4107-4113. PubMed ID: 35861599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed inflammatory reaction to dermal fillers after COVID-19 vaccination: a case report.
    Beamish IV; Bogoch II; Carr D
    CJEM; 2022 Jun; 24(4):444-446. PubMed ID: 35294771
    [No Abstract]   [Full Text] [Related]  

  • 13. Facial Dermal Filler Injection and Vaccination: A 12-Year Review of Adverse Event Reporting and Literature Review.
    Sun AH; Tiongco RFP; Manahan MA
    Aesthet Surg J; 2023 Jun; 43(7):NP544-NP557. PubMed ID: 36788718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hypersensitivity reaction to hyaluronic acid dermal filler post-COVID-19 viral infection.
    Shome D; Doshi K; Vadera S; Kapoor R
    J Cosmet Dermatol; 2021 May; 20(5):1549-1550. PubMed ID: 33682241
    [No Abstract]   [Full Text] [Related]  

  • 15. Delayed hypersensitivity reaction to hyaluronic acid dermal filler following influenza-like illness.
    Turkmani MG; De Boulle K; Philipp-Dormston WG
    Clin Cosmet Investig Dermatol; 2019; 12():277-283. PubMed ID: 31118731
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed adverse reaction to a natural dermal filler mimicking salivary gland neoplasia.
    Alli N; Murdoch M; Meer S
    Bull Natl Res Cent; 2022; 46(1):97. PubMed ID: 35431534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection.
    Virdi G
    Cureus; 2022 Apr; 14(4):e24461. PubMed ID: 35637833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localised swelling at sites of dermal filler injections following administration of Covid-19 vaccines: a systematic review.
    Ng CL; Tay EY; D'Souza AR
    Singapore Med J; 2023 Apr; ():. PubMed ID: 37077055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, prospective, blinded, split-face, single-center study comparing polycaprolactone to hyaluronic acid for treatment of nasolabial folds.
    Galadari H; van Abel D; Al Nuami K; Al Faresi F; Galadari I
    J Cosmet Dermatol; 2015 Mar; 14(1):27-32. PubMed ID: 25564797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report of possible iatrogenic Cushing's disease with low-dose prednisone to treat dermal filler hypersensitivity.
    Grillo R
    J Cosmet Dermatol; 2022 Dec; 21(12):6702-6705. PubMed ID: 36107714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.